Brief: 5-Year Head & Neck Cancer Survival Increased From 45% To 73% In CEL-SCI’s Target Population

CEL-SCI

23/10/2023 14:36

Oct 23 (Reuters) - CEL-SCI Corp  CVM.A :
    * 5-YEAR HEAD & NECK CANCER SURVIVAL INCREASED FROM 45% TO
73% IN
CEL-SCI’S TARGET POPULATION, CUTTING RISK OF DEATH IN HALF, AS
PRESENTED AT LEADING CANCER CONFERENCE ESMO 2023
    * CEL-SCI- PLAN TO SEEK IMMEDIATE APPROVAL FOR COMMERCIAL
DISTRIBUTION WITHOUT HAVING TO WAIT FOR COMPLETION OF
CONFIRMATORY STUDY IN THIS TARGET POPULATION

Source text for Eikon:  ID:nBw16D8Tma 
Further company coverage:  CVM.A 

 ((Reuters.Briefs@thomsonreuters.com;))